Bare Lymphocyte Syndrome, Type I
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|
Bronchiectasis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Bronchiolitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ectopia Lentis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Pathological accumulation of air in tissues
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nasal Polyps
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Skin Ulcer
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Chronic sinusitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Chronic otitis media
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent bronchitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
A heterogeneous expression pattern of MHC class I antigens, TAP peptide transporter, proteasome subunits, proteasome activator PA28 and the chaperones calnexin, calreticulin as well as tapasin was displayed by these tumor cell lines.
|
10933198 |
2000 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Its restoration by cytokines further suggests that impaired tapasin expression in tumors is rather due to dysregulation than to structural alterations.
|
11169257 |
2001 |
Neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
|
11260505 |
2001 |
Central neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
|
11260505 |
2001 |
Childhood Neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
|
11260505 |
2001 |
Bare Lymphocyte Syndrome, Type I
|
0.610 |
Biomarker
|
disease |
BEFREE |
These results suggest that tapasin deficiency is another cause of type I BLS.
|
12149238 |
2002 |
Bare Lymphocyte Syndrome, Type I
|
0.610 |
GermlineCausalMutation
|
disease |
ORPHANET |
A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination.
|
12149238 |
2002 |
Bare Lymphocyte Syndrome, Type I
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination.
|
12149238 |
2002 |
Severe Combined Immunodeficiency
|
0.010 |
Biomarker
|
disease |
LHGDN |
A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination.
|
12149238 |
2002 |
melanoma
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
The downregulation of tapasin in advanced stages of human melanoma may reflect the accumulation of alterations in the antigen-presenting/processing machinery associated with neoplastic progression.
|
12682852 |
2003 |
Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical staining of 51 formalin-fixed RCC lesions and autologous normal renal epithelium detected transporter associated with antigen processing (TAP)1 and tapasin deficiencies in 63 and 80% of the tumor lesions.
|
12738726 |
2003 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical staining of 51 formalin-fixed RCC lesions and autologous normal renal epithelium detected transporter associated with antigen processing (TAP)1 and tapasin deficiencies in 63 and 80% of the tumor lesions.
|
12738726 |
2003 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Both tapasin and HLA class I antigen expression were significantly correlated with the number of infiltrating CD3(+) T cells into tumor lesions (P < 0.01); furthermore, tapasin expression was significantly correlated with tumor differentiation (P = 0.024).
|
14519625 |
2003 |
Maxillary Sinus Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
|
14519625 |
2003 |
Maxillary Sinus Squamous Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Tapasin expression appears to be associated with HLA class I antigen expression in primary maxillary sinus SCC lesions.
|
14519625 |
2003 |